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A B S T R A C T
A pilot survey was performed to determine the presence of known risk factors for cardiovascular disease in Croatian
patients with diagnosed coronary heart disease (CHD) using a new questionnaire. The idea was to test this new and very
simple questionnaire but also to compare the data collected in this pilot survey with the results of the last Croatian na-
tional survey (TASPIC-CRO V) and so to obtain the information whether secondary prevention has improved between
2003 and 2010. 122 patients with established CHD (88 men, 34 women, mean age 66.3 years) treated in Zagreb Univer-
sity Hospital Center were included. Data collection was based on filling the SURF questionnaire right after the clinical
exam or later using review of medical records. Patients were hospitalized because of CABG (1%), PCI (8%), ACS (35%) or
chronic stable angina (56%). The history of arterial hypertension had 95% patients (however, on admission mean systolic
pressure was 130.1 mmHg, diastolic 76.8 mmHg), 90% had dyslipidaemia ( total cholesterol <4.5 mmol/L had 43%;
<4.0 mmol/L 33%; LDL-cholesterol <2.5 mmol/L 49%; <2.0 mmol/L 32%; HDL>1.2 mmol/L (women) or >1.0 mmol/L
(men) had 67%), 25% had diabetes which was poorly regulated (mean HbA1c 8.2%), 18% were active smokers. After dis-
charge only 24% performed cardiac rehabilitation. Mean body mass index of the patients was 28.3 kg/m2 (32% were
obese, 72% overweight). Compared to TASPIC-CRO V there was lower usage of aspirin than recommended on discharge.
This was also true for statin therapy. More patients were taking beta blockers, calcium antagonists and diuretics than 7
years ago. This pilot survey showed that CRO-SURF questionnaire is short, quick, effective and simple to use. It is a
good and cost effective tool to collect data on CVD risk factors and their management. The results obtained by using it in-
dicate that there is still a high prevalence of modifiable risk factors in Croatian patients with CHD.
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Introduction
Cardiovascular disease (CVD) is the most important
cause of death in Croatia and worldwide1. Most impor-
tant risk factors for CVD such as smoking, increased se-
rum cholesterol, elevated blood pressure, diabetes, physi-
cal inactivity, overweight and obesity are well defined
and modifiable2–4. Risk factor modification reduces mor-
tality, especially in patients with established CVD5. The
efficacy of risk factor intervention in subjects with estab-
lished coronary heart disease (CHD) who are at highest
risk in different European countries has been shown in
EUROASPIRE III survey6. Croatia participated in this
survey and the results for Croatia were very similar to
the average European results7. This survey showed that
CVD risk factor control is not optimal. Many patients
who are at highest risk for the next cardiovascular event
have not achieved the risk factor targets as established
by the Joint European prevention guidelines8. However,
the problem with EUROASPIRE was that the protocol
and questionnaire were very complex and that the cost of
this survey was very high. Therefore such an approach is
not appropriate to be used in everyday life for collecting
data in a simple and inexpensive way. Since there was a
need for a much simpler method of investigating the
CVD risk factor control in patients with established
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CHD, a new questionnaire was developed and a pilot sur-
vey was performed to test it in Croatia. The obtained
data may complement the information collected by EU-
ROASPIRE and expand them.
The aim of this pilot study was, using SURF question-
naire, to determine its efficacy but also to investigate
whether there is any improvement concerning the risk
factors in Croatian patients with CHD when compared
with the results of TASPIC-CRO – the last survey per-
formed on Croatian CHD patients seven years ago9.
Sample and Methods
122 consecutive patients (88 men, 34 women) were in-
cluded in this pilot survey. This number was based upon
previously performed power analysis. Most of them were
recruited in Department of Cardiovascular Diseases (104)
and 18 were recruited in Department for Internal Dis-
eases, Zagreb University Hospital Center. Data were col-
lected by the bedside by doctors and specialised nurses.
Inclusion criteria were: The history of CHD, Coronary
artery bypass surgery (CABG), percutaneous coronary
intervention (PCI), acute coronary syndrome (ACS – car-
diac chest pain at rest with serial ischaemic ECG changes
and/or a rise in troponin or CKMB levels), or stable an-
gina pectoris (clinical angina pectoris with at least one of:
positive exercise ECG; positive stress myocardial perfu-
sion scan or at least one stenosis of 70% or more on coro-
nary arteriography). Demographic data included date of
birth, date of examination, category of CHD and whether
the patient was admitted in the previous one year. Infor-
mation on attendance at cardiac rehabilitation was no-
ted, smoking, physical activity, educational level, history
of known hypertension, dyslipidaemia and diabetes as
well. Drug usage was recorded by category only. Data
were stored in predefined spread sheets and upon com-
pletion forwarded to the data collection centre. Continu-
ous variables are presented as arithmetic means ± SD if
normally distributed. If not, medians and geometric me-
ans are used. Categorical variables are presented as per-
centages.
Results
This pilot project included 122 patients (mean age
66.3 years). The reason of hospitalisation was as follows:
CABG 1%; PCI 8%; ACS 35%; chronic stable angina 56%.
95% of patients had arterial hypertension, 90% had dysli-
pidaemia and 25% diabetes. Every fifth patient (18%)
still smokes, and about the same number quitted smok-
ing (20%), 62% have never smoked. After the discharge
from hospital only 24% of patients performed some form
of specialized cardiac rehabilitation (Figure 1).
Mean systolic blood pressure was 130.1 mmHg (me-
dian 130.0 mmHg) and diastolic pressure was 76.8 mmHg
(median 80.0 mmHg). Mean heart rate was 79.8 beats per
minute.
Laboratory control (lipids, blood glucose) within one
year to admission to hospital had 74% of patients. Mean
total cholesterol values were 4.8 mmol/L (median 4.8);
HDL-cholesterol 1.2 mmol/L (median 1.1); LDL-choles-
terol 2.7 mmol/L (median 2.6); and triglycerides 1.9
mmol/L (median 1.5). Mean glucose in diabetic patients
was 8.3 mmol/L (6.0 mmol/L for non-diabetics). Patients
with diabetes were poorly regulated (mean HbA1c 8.2%)
(Figure 2).
Blood pressure <140/90mmHg had 68% of patients and
130/80mmHg had 60%. Total cholesterol <4.5 mmol/ L
had 43%; <4.0 mmol/L 33%; LDL-cholesterol <2.5 mmol/
L had 49%; <2.0 mmol/L had 32%; HDL-cholesterol>1.2
mmol/L (in women) or >1.0 mmol/L in men had 67% pa-
tients.
Mean body mass index was 28.3 kg/m2. 32% patients
were obese and 72% were overweight. Less than recom-
mended regular physical activity performed 62% of pa-
tients, and recommended physical activity performed
only 33%. More than recommended performed 4%.











CABG PCI AP ACS Never smoked
Current Ex smoker Less Recommended More than
Hypertension Dyslipidemia Diabetes Yes No
CHD cat. Smoking Physical activity Anamnesis of Cardiac rehab.
%
Fig. 1. Anamnestic data gained from questionnaire. CHD-Cor-
onary heart disease; PCI-Percutaneous coronary intervention;



















BP<140/90 mmHg BP<130/80 mmHg TC<4.5 mmol/L TC<4.0 mmol/L
HDL>1.2 mmol/L LDL<2.5 mmol/L LDL<2.0 mmol/L
Fig. 2. The achieved targets in control of risk factors for CVD.
71% of patients used antiplatelet drugs, 59% used
statins, 12% other lipid lowering agents, beta blockers
63%, calcium channel blockers 28%, ACE inhibitors 54%,
angiotensin receptor blockers 14%, other hypertensives
11%, nitrates 34%, diuretics 40%, 12% were taking oral
hypoglicemic agents and 17% of patients were on insulin
therapy (Figure 3).
Discussion
This Croatian pilot survey (CRO-SURF) showed a
high prevalence of modifiable CHD risk factors in pa-
tients who are at very high risk of developing a new car-
diovascular event. Patients with established CHD still
use less prophylactic drugs than recommended. Thera-
peutic goals set by recent guidelines were not achieved by
too many patients.
CRO-SURF had two goals. The first was to explore
the practical side of a new questionnaire and whether it
is applicable in everyday practice, and the second was to
examine whether any positive or negative trend exists in
CHD patients concerning CVD risk factors (dyslipidae-
mia, arterial hypertension, diabetes, smoking, usage of
recommended drugs) when compared with the results of
the last national survey named TASPIC-CRO that was
performed almost a decade ago. Namely, TASPIC-CRO
(Treatment and Secondary Prevention of Ischemic Coro-
nary events in CROatia) was a Croatian national survey
also performed with the aim to determine the status of
major risk factors for coronary heart disease in patients
with established CHD. TASPIC-CRO used methodology
similar to EUROASPIRE study (6). TASPIC-CRO I was
performed in 1998 and TASPIC-CRO V in 2002–2003.
Concerning the first goal, CRO-SURF showed that
the usage of the new short questionnaire is efficient, is it
not time consuming, does not demand any additional
cost, clinicians or nurses can perform it upon admission
to hospital or at any time during hospitalisation (it takes
only about 60–90 seconds per patient to fill in the ques-
tionnaire) and it can be done by the bedside. Following
positive experience from this national pilot survey a full
survey on much more patients will be performed.
Concerning the second goal, CRO-SURF indicated
that some of the negative trends still exist. For example,
65% Croatian patients with established CHD in TASPIC-
CRO V had elevated total cholesterol and in CRO-SURF
57% of such patients were still not achieving target val-
ues. However, it has to be stressed that he target value
was changed in the meantime from <5.0 mmol/L to
<4.5mmol/L. A positive trend is supported by the data
showing that LDL-cholesterol below 2.0 mmol/L achie-
ved only 68% patients in CRO-SURF while the same per-
centage of patients achieved <3.0 mmol/L LDL-choles-
terol which was the target value when TASPIC-CRO V
was performed. A very moderate positive trend was shown
also concerning prevalence of HDL cholesterol. In TAS-
PIC-CRO V 63% patients had recommended values, and
in CRO-SURF 67% which, however, is not a significant
change.
Smoking in Croatian CHD patients shows also a posi-
tive trend. In TASPIC-CRO V 34% patients were smok-
ers, and in CRO-SURF only 18% were current smokers
while 20% were ex-smokers.
A moderate positive trend was also recorded concern-
ing the prevalence of diabetes (TASPIC-CRO 30% vs.
CRO-SURF 25%), but the control of diabetes in these pa-
tients is still poor (mean HbA1c 8.2%).
The fact that only 24% of CHD patients attended car-
diac rehabilitation is absolutely not satisfactory and should
be urgently improved.
Some changes concerning the usage of recommended
drug therapy have been noticed. Values that were com-
pared are those that were recommended upon discharge
from the hospital (TASPIC-CRO) and one noted upon ad-
mission to hospital (CRO-SURF). The trend of less using
aspirin (TASPIC vs. SURF; 84% vs. 71%) can been seen.
However, during TASPIC survey clopidogrel was still not
fully reimbursed by the Croatian National Health Insur-
ance Institute. This is probably the reason why today less
aspirin is used. More than 70% patients were prescribed
statins, but only 59% were still using it on admission in
CRO-SURF. This is much better than only 28% on admis-
sion in TASPIC-CRO V. ACE inhibitors had the same
trend (TASPIC vs. SURF; 52% vs. 54%). There is positive
trend in usage of beta blockers and calcium antagonists
(TASPIC-CRO V vs. CRO-SURF; 49% and 19% vs. 63%
and 28% respectively). There is also an increasing trend
in usage of diuretics which is hard to explain (TASPIC-
CRO vs. CRO-SURF; 30% vs. 40%). Clearly there are
more positive than negative trends but almost all ob-
served values in CHD patients are still far away from
those recommended8,10.
The fact that there were more than 70% of men
among consecutive CHD patients might reflect not only
higher incidence of CHD in males but also neglecting the
signs and symptoms of CHD in women.
This pilot survey has its strengths and limitations.
Among strengths the ease of administration should be
mentioned as well as its cost effectiveness. The limita-
tions include small number of patients for a survey, only






















Recommended medication usage (%)
Antiplatelet Statins Other LRA Beta-B CaCB ACEi
ARB Other AH Nitrates Diuretics OHA Insulin
Fig. 3. Drug usage upon admission to hospital.
one center included which was chosen at the discretion of
the investigators and therefore the representativeness of
the results for the whole country is unknown. Labora-
tory measurements were not standardised but this should
not be seen as a limitation since it is local results that are
always used to trigger intervention in prevention.
According to the results of CRO-SURF as well as the
results of EUROASPIRE III6 and TASPIC-CRO9, it is
clearly visible that secondary prevention of ischaemic
coronary events in Croatia is not good enough and that
established and well known CHD risk factors are still not
dealt with in appropriate way. This differs substantially
from the perception which both, Croatian physicians and
general public, have concerning this issue11,12.
The results from this pilot survey are alarming indi-
cating that there is still much to do in secondary preven-
tion in patients with established CHD in Croatia. Fur-
ther surveys on much bigger patients samples are needed
to confirm the conclusions of this survey but the results
are worrying and they suggest that a great potential ex-
ists in reducing the risk of cardiovascular morbidity and
mortality in Croatia.
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CRO-SURF: HRVATSKI PILOT-PROJEKT ISPITIVANJA ^IMBENIKA RIZIKA U BOLESNIKA
S KARDIOVASKULARNIM BOLESTIMA
S A @ E T A K
Ovaj je pilot projekt proveden kako bi se istra`ila prisutnost ~imbenika rizika za kardiovaskularne bolesti u hrvat-
skih bolesnika s dijagnosticiranom koronarnom sr~anom bolesti (KBS) koriste}i novi upitnik. Cilj je bio isprobati ovaj
novi i vrlo jednostavan za uporabu upitnik te dobivene rezultate iz ovog pilot projekta usporediti s rezultatima pos-
ljednjeg istra`ivanja na nacionalnoj razini (TASPIC-CRO V), a sve s ciljem dobivanja informacije da li se sekundarna
prevencija pobolj{ala u razdoblju od 2003. do 2010. Ukupno 122 ispitanika s definiranom KBS uklju~eno je u ovaj pi-
lot-projekt (88 mu{karaca, 34 `ena, srednje dobi 66,3 godina) lije~enih pri Klini~kom bolni~kom centru Zagreb-Rebro,
Zagreb, Hrvatska. Podaci su bazirani na ispunjavanju SURF upitnika odmah nakon klini~kog pregleda. 122 bolesnika
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hospitalizirano je zbog CABG (1%), PCI (8%), ACS (35%) ili kroni~ne stabilne angine (56%). Anamnezu arterijske
hipertenzije imalo je 95% ispitanika (ali prilikom primitka u bolnicu srednji sistoli~ki arterijski tlak bio je 130,1 mmHg,
dijastoli~ki 76,8 mmHg), 90% ispitanika imalo je dislipidemiju (ukupni kolesterol <4,5 mmol/L imalo je 43%; <4,0
mmol/L 33%; LDL-kolesterol <2,5 mmol/L 49%; <2,0 mmol/L 32%; HDL>1.2 mmol/L (`ene) ili >1.0 mmol/L (mu{kar-
ci) imalo je 67%), 25% {e}ernu bolest koja je bila lo{e regulirana (srednji HbA1c 8,2%), 18% je bilo aktivnih pu{a~a. Po
otpustu iz bolnice samo 24% ispitanika provelo je propisanu kardiolo{ku rehabilitaciju. Srednja vrijednost indeksa
tjelesne mase bila je 28,3 kg/m2 (32% pretilo, 72% prekomjerno te{ko). U usporedbi s TASPIC-CRO V prati se trend
manje uporabe acetil-salicilne kiseline. Ovaj trend prati se i vezano uz terapiju statinima. Vi{e bolesnika uzima beta
blokatore, antagoniste kalcijskih kanala i diuretika nego {to je to bio slu~aj prije 7 godina. Ovaj pilot-projekt s kratkim
CRO-SURF upitnikom pokazuje kako je kratak, koristan i lak za uporabu u svakodnevnoj klini~koj praksi. Pokazuje se
kao dobar i isplativ alat za sakupljanje podataka vezanih uz ~imbenike rizika za kardiovaskularne bolesti. Rezultati
proiza{li iz njega ukazuju na jo{ uvijek visoku prevalenciju promjenjivih ~imbenika rizika u hrvatskih bolesnika s KBS.
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